financetom
Business
financetom
/
Business
/
TransUnion's Q3 Adjusted Earnings, Revenue Rise; Provides Q4 Outlook, Raises 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TransUnion's Q3 Adjusted Earnings, Revenue Rise; Provides Q4 Outlook, Raises 2024 Guidance
Oct 23, 2024 4:37 AM

07:12 AM EDT, 10/23/2024 (MT Newswires) -- TransUnion ( TRU ) reported Q3 adjusted earnings Wednesday of $1.04 per diluted share, up from $0.91 a year earlier.

Analysts polled by Capital IQ expected $1.01.

Revenue for the quarter ended Sept. 30 was $1.09 billion compared with $968.7 million a year earlier.

Analysts surveyed by Capital IQ expected $1.06 billion.

For Q4, the company expects adjusted diluted earnings per share in a range of $0.92 to $0.98 on revenue of between $1.01 billion and $1.03 billion. Analysts polled by Capital IQ expect adjusted earnings per share of $0.97 on revenue of $1.02 billion.

The company raised its 2024 adjusted diluted earnings per share guidance to $3.87 to $3.93 from $3.78 to $3.90. Analysts surveyed by Capital IQ expect $3.90. The company also increased its revenue guidance for the year to $4.16 billion to $4.18 billion from $4.10 billion to $4.14 billion. Analysts polled by Capital IQ expect $4.14 billion.

Price: 105.50, Change: -0.28, Percent Change: -0.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PRESS DIGEST- Financial Times - March 5
PRESS DIGEST- Financial Times - March 5
Mar 4, 2024
March 5 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Cinven agrees to buy majority stake in fund administrator Alter Domus - Jeremy Hunt set to give motorists 5 bln pound tax break in the Budget - 'Erroneous' filings highlight flaws...
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
Mar 4, 2024
March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ): * TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE PRODUCTION PLATFORM * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO BE FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO HAVE POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX...
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
Mar 4, 2024
March 5 (Reuters) - BowFlex Inc ( BFX ): * BOWFLEX INC. ( BFX ) FILES FOR VOLUNTARY CHAPTER 11 PROTECTION AND REACHES STALKING HORSE AGREEMENT TO FACILITATE SALE * BOWFLEX ( BFX ) - SECURED COMMITMENT FOR $25 MILLION IN DIP FINANCING TO CONTINUE TO FULFILL CUSTOMER ORDERS AND SUPPORT ORDINARY COURSE OPERATIONS * BOWFLEX ( BFX ) :...
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Mar 4, 2024
05:31 PM EST, 03/04/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday it plans a private placement of $250 million in principal amount of convertible notes due 2029. Initial purchasers will have the option to buy up to an additional $37.5 million principal amount of notes, according to the company. Net proceeds, along with cash at hand,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved